Skip to main content

Find Clinical Trials

Home
Conditions
High-grade Cervical Intraepithelial Neoplasia

Clinical trial condition

High-grade Cervical Intraepithelial Neoplasia

Explore clinical trials studying High-grade Cervical Intraepithelial Neoplasia. Study availability and eligibility vary by location and protocol.

5 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

High-grade Cervical Intraepithelial Neoplasia trial results

Active, not recruiting

Randomized Implementation of Primary HPV Testing in the Organized Screening for Cervical Cancer in Stockholm

NCT01511328

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +12 more
Locations: Karolinska University Hospital Stockholm, Sweden

View Trial Details

Completed

Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection.

NCT03697226

Conditions: CIN - Cervical Intraepithelial Neoplasia, Cervical Cancer, Cervical Dysplasia, +24 more
Locations: Research Center Bloemfontein, Free State, South Africa

View Trial Details

Completed

Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection

NCT03239223

Conditions: CIN, Cervical Cancer, Cervical Dysplasia, +25 more
Locations: Research Center Los Angeles, California, United States

Research Center Lake Worth, Florida, United States

Research Center Idaho Falls, Idaho, United States

Research Center Chapel Hill, North Carolina, United States

View Trial Details

Completed

Focal Ablation of Cervical Precancer

NCT01709773

Conditions: High-grade Cervical Intraepithelial Neoplasia
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Completed

An Alternative Treatment for Cervical Intraepithelial Neoplasia Using the Focal Loop Electrosurgical Excision Procedure

NCT02220192

Conditions: High-grade Cervical Intraepithelial Neoplasia
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details